Home Pregenen

Pregenen

acquired
-
New Generation Cell Gene Therapy Technology Company

Basic Information

Pregenen designs and engineers molecules that are crucial for the next generation of cell-based therapies, addressing unmet medical needs. We collaborate with our partners to apply our tools, services, and reagents, enhancing the reliability, efficacy, and safety of a new wave of therapies that leverage the specificity and functional capabilities of molecules and cells produced by the human body.
Pregenen
Seattle,Washington,United States of America
unclear
January 01, 2006
info@bluebirdbio.com